Compounds > naphthalimides
Page last updated: 2024-08-24

naphthalimides and Central Nervous System Diseases

naphthalimides has been researched along with Central Nervous System Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benavides, A; Casado, A; Díaz-Rubio, E; López-Vega, JM; Martín, M1

Trials

1 trial(s) available for naphthalimides and Central Nervous System Diseases

ArticleYear
Phase I study of mitonafide with a 3-day administration schedule: early interruption due to severe central nervous system toxicity.
    Investigational new drugs, 1994, Volume: 12, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Central Nervous System Diseases; Drug Administration Schedule; Female; Humans; Imides; Isoquinolines; Male; Middle Aged; Naphthalimides; Neoplasms

1994